Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

J&J’s appeal shot down over $2.12m payment due to allegedly carcinogenic talc products

November 4, 2020 Research and Development, Sales and Marketing J&J, JJ, baby powder, ovarian cancer, talc

Johnson & Johnson has suffered a legal defeat in its ongoing dispute with consumers over damages relating to use of …
News

Pfizer announces €300m investment in Irish manufacturing sites

November 2, 2020 Sales and Marketing

Pfizer is set to invest €300 million in its three Irish manufacturing sites in Ringaskiddy, Dublin and Kildare.  The investment …
News

Johnson & Johnson to begin testing COVID-19 vaccine on adolescent patients

November 2, 2020 Sales and Marketing

Johnson & Johnson plans to start testing its COVID-19 vaccine candidate in adolescents between the age of 12 and 18.  …
News

Pharmasyntez asks Russian Government for permission to produce generic version of remdesivir for COVID-19

November 2, 2020 Sales and Marketing

Russian drug firm Pharmasyntez has asked the government for permission to produce a generic version of Gilead’s remdesivir without a …
News

Sanofi angles to buy Kiadis for €308 million

November 2, 2020 Sales and Marketing Sanofi, kiadis, pharma

Sanofi has announced it is poised to buy out Amsterdam-based biopharma firm Kiadis in an all-cash public offer of €308 …
News

LEO Pharma’s delgocitinib hits main goals in moderate-to-severe chronic hand eczema

November 2, 2020 Research and Development, Sales and Marketing LEO Pharma, eczema, pharma

LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology (EADV) Virtual 2020 Virtual Congress …
News

Parag Agarwal appointed as Dr Reddy’s Laboratories Chief Financial Officer

October 30, 2020 Sales and Marketing

Dr Reddy’s Laboratories has appointed Parag Agarwal has the company’s new Chief Financial Officer. Parag has a career that spans …
Appointment

NICE recommends Novo’s liraglutide for management of obesity and non-diabetic hyperglycaemia

October 30, 2020 Medical Communications, Sales and Marketing NICE, Novo Nordisk, liraglutide

Novo Nordisk’s pre-filled injection Saxenda (liraglutide) has received the backing of drug watchdog NICE, meaning it will now be made …
News

AstraZeneca jettisons two heart drugs to Cheplapharm in $400m deal

October 30, 2020 Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Cheplapharm

AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …
News

European Commission greenlights Insmed’s Arikayce for nontuberculous mycobacterial lung infections

October 29, 2020 Sales and Marketing Arikayce, EU, lungs, pharma

The European Commission (EC) has given approval to Insmed Incorporated’s Arikayce (liposomal 590mg nebuliser dispersion) for the treatment of nontuberculous …
News

FDA approves Sanofi’s ivermectin head lice treatment for over-the-counter use

October 29, 2020 Sales and Marketing

The FDA has approved Sanofi’s Sklice (ivermectin) for over-the-counter use.  Sklice is a single-use lotion that includes ivermectin 0.5% as …
News

Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan

October 29, 2020 Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine

Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …
News

US reserves 300,000 doses of Lilly’s COVID-19 treatment in $375 million deal

October 28, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Eli Lilly, US, pharma

The US Government has signed a $375 million deal with Eli Lilly to buy 300,000 700mg doses of bamlanivimab, its …
News

The November 2020 issue of Pharmafocus is available to read free online now!

October 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir

The latest monthly edition of Pharmafocus is available to read for free online now!
News

Bayer buys out US-based Asklepios BioPharmaceutical in potential $4bn deal

October 26, 2020 Sales and Marketing Asklepios, Bayer, acquisition, pharma

Bayer has moved to bolster its cell and gene therapy (CGT) business through the acquisition of US biotech Asklepios BioPharmaceutical …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026